Skip to main content
Krakchemia S.A. logo

Krakchemia S.A. — Investor Relations & Filings

Ticker · KCH ISIN · PLKRKCH00019 LEI · 259400QGYEAGRYCQ5Y56 WAR Wholesale and retail trade
Open in API
Filings indexed 587 across all filing types
Latest filing 2017-07-14 Regulatory Filings
Country PL Poland
Listing WAR KCH

About Krakchemia S.A.

https://www.krakchemia.pl/en

Krakchemia S.A. is a distributor specializing in the wholesale trade of chemical products and plastics. The company's core offerings include a wide range of plastic raw materials, such as granules, and various types of packaging films. Its product portfolio also encompasses laboratory chemicals, reagents, and other chemical raw materials for industrial and commercial applications. The company provides value-added services, including the slitting and rewinding of films, utilizing modern machinery for materials intended for food contact.

Recent filings

Filing Released Lang Actions
ZAWARCIE ISTOTNEJ UMOWY Z KONTRAHENTEM - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1068 characters) from the Management Board of KRAKCHEMIA S.A. regarding the signing of a supply agreement with Basell Orlen Polyolefins Sprzedaż Sp. z o.o. (BOPS). It details the subject matter (polyolefin products), the term (until September 30, 2017), and a condition precedent (providing a bank guarantee). Crucially, it also references a previous report (raportu nr 30/2017) and states that a condition related to a multi-purpose credit limit agreement with Bank Pekao S.A. has not been met because the new contract term is shorter than required. This content relates to a significant business transaction and its impact on existing financing arrangements, which often falls under material event disclosures. Given the nature of reporting a specific contract signing and its implications for financing, it is most closely related to a significant business transaction or financing update. However, since it is a specific announcement of a contract and its immediate financial/credit implications, and not a general financing raise (CAP) or a general regulatory filing (RNS), it fits best under the category for significant business/transaction updates. Since there isn't a specific 'Material Event Disclosure' code, and it deals with a contract that impacts a credit limit, it is a significant business event. In the provided list, 'TAR' (M&A Activity) is too specific. 'CAP' (Capital/Financing Update) is plausible due to the credit limit discussion, but the core event is the supply contract. Given the context of reporting material information under MAR (Art. 17 ust 1 MAR), and the lack of a perfect fit for a general material contract disclosure, I will evaluate the closest options. It is not an ER, IR, or 10-K. It is not a management change (MANG) or director dealing (DIRS). It is a specific business contract announcement. If this were a US filing, it might be an 8-K item 1.01 or 2.03. Among the options, 'CAP' (Capital/Financing Update) is the closest fit because the primary consequence discussed is the failure to meet a condition related to a credit facility. Alternatively, 'RNS' (Regulatory Filings) is a fallback for material announcements not covered elsewhere. Given the specific mention of the credit limit condition, 'CAP' is slightly more descriptive than the general 'RNS'. I will classify it as 'CAP' due to the direct link to the credit facility condition, which is a financing matter, despite the primary subject being a supply contract. The document is short and is the announcement itself, not a report about the announcement, so RPA is not applicable.
2017-07-14 Polish
OTWARCIE LIKWIDACJI SPÓŁEK ZALEŻNYCH - Content (PL)
AGM Information Classification · 99% confidence The document is a short announcement (1177 characters) from the Management Board of KRAKCHEMIA S.A. written in Polish. It details decisions made during extraordinary general meetings (nadzwyczajne zgromadzenie wspólników/walne zgromadzenie akcjonariuszy) of two subsidiary companies regarding their dissolution and liquidation, effective June 30, 2017. This concerns corporate structure changes and the winding down of subsidiaries, which falls under significant corporate actions. Since it is an announcement of a corporate event (dissolution/liquidation of subsidiaries) and not a standard financial report (like 10-K or IR), it must be classified. It is not a Director's Dealing (DIRS), Dividend (DIV), or Capital Change (SHA/CAP). The closest fit for significant corporate restructuring/winding down, especially when announced via regulatory channels (implied by 'art. 17 – MAR'), is often captured under general regulatory announcements or specific corporate action codes. Given the options, this relates to fundamental changes in the corporate structure/subsidiaries, which is a significant event. It is not a proxy statement (PSI), AGM material (AGM-R), or a standard earnings release (ER). Since it details a major corporate action (dissolution/liquidation of subsidiaries), and there isn't a specific 'Corporate Restructuring' code, it is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure under MAR (Market Abuse Regulation) regarding material information about subsidiaries, or potentially related to Capital/Financing Update (CAP) if viewed as a change in capital structure, but RNS is the safer fallback for mandatory MAR disclosures that don't fit elsewhere. Given the nature of dissolving subsidiaries, RNS is the most appropriate general regulatory disclosure category.
2017-06-30 Polish
PODPISANIE ANEKSU DO UMOWY Z BANKIEM POLSKA KASA OPIEKI S.A. - Content (PL)
Capital/Financing Update Classification · 99% confidence The document is a short regulatory announcement from KRAKCHEMIA S.A. (indicated by the Polish text structure and reference to 'raport bieżący' - current report, and Art. 17 ust. 1 – MAR, which is the Market Abuse Regulation). The content details a specific amendment (aneks) to a multi-purpose credit limit agreement with a bank, involving deadlines and conditions related to another cooperation agreement. This is a material event disclosure concerning financing and contractual obligations. Since it is a specific announcement about a material change in financing/credit terms, it fits best under 'Capital/Financing Update' (CAP). It is too specific for a general 'Regulatory Filing' (RNS) and does not relate to dividends, management changes, or share transactions.
2017-06-30 Polish
WYGAŚNIĘCIE UMOWY KREDYTU W FORMIE LIMITU KREDYTOWEGO WIELOCELOWEGO - Content (PL)
Capital/Financing Update Classification · 99% confidence The document text, written in Polish, discusses the expiration and final repayment of a multi-purpose credit limit facility (umowa kredytu w formie limitu kredytowego wielocelowego) on June 30, 2017. It references previous regulatory reports (raportem bieżącym) detailing the initial agreement and subsequent amendments. The core subject is a change in the company's financing/debt structure (the expiration and repayment of a credit line). This aligns directly with the definition for Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2017-06-30 Polish
NABYCIE AKCJI SPÓŁKI ORAZ ZMIANA UDZIAŁU W OGÓLNEJ LICZBIE GŁOSÓW - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document is a formal notification ('zawiadomienie') from IPOPEMA Towarzystwo Funduszy Inwestycyjnych S.A. to KRAKCHEMIA S.A. It explicitly references Polish public offering laws (art. 69 and art. 87 of the Act on Public Offering) regarding changes in share ownership thresholds. The content details the acquisition of shares by an investment fund managed by the notifier, causing the total voting rights to cross the 25% threshold and change by more than 2%. This precisely matches the definition of a Major Shareholding Notification (notification of changes in significant share ownership levels crossing thresholds).
2017-06-21 Polish
ZAWIADOMIENIE O NABYCIU AKCJI PRZEZ PODMIOT BLISKO ZWIĄZANY Z OSOBĄ PEŁNIĄCĄ OBOWIĄZKI ZARZĄDCZE - Content (PL)
Director's Dealing Classification · 99% confidence The document text is a formal notification received by KRAKCHEMIA S.A. regarding a transaction involving shares by a person closely associated with a management executive (Jerzy Mazgaj, Chairman of the Supervisory Board). The content details the buyer (IPOPEMA 2 FUNDUSZ), the transaction type ('Kupno' - Purchase), the price (1.59 PLN), and the volume (525,415 shares) on a specific date (2017-06-19). This structure perfectly matches the definition of Director's Dealing or insider transaction reporting, which corresponds to the 'DIRS' filing type code (Director's Dealing). The reference to 'Art. 19 MAR' (Market Abuse Regulation Article 19) confirms this is an insider transaction disclosure.
2017-06-21 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.